Characterizing the Neuropharmacology of Dexmedetomidine Through Trimodal Imaging
Characterizing the Neuropharmacology of Dexmedetomidine Through Trimodal Imaging
The investigators will be studying the sedative drug dexmedetomidine using hybrid PET/fMRI/EEG imaging to better understand the neuropharmacology of anesthesia/artificially induced sleep.
A group of healthy volunteers will undergo simultaneous PET/fMRI/EEG imaging under two different conditions: while being administered a sedative (dexmedetomidine), and while being administered a normal saline infusion, as a control. The order of these two scans will be randomized, and the study design is open label (ie subjects and investigators know which session will be the control scan and which one will be the sedative scan). Investigators hope that by comparing the results of the sedative and control scans, the different neuromodulatory states involved in the transition from wakefulness to medically induced vs naturally occurring sleep can be better understood.
Inclusion Criteria:
Exclusion Criteria:
ibass@mgh.harvard.edu617-726-9034
csander@mgh.harvard.edu617-726-9034